Nautilus Biotechnology Inc

NASDAQ:NAUTUnited States

Nautilus Biotechnology, Inc. is a development stage life sciences company. The Company is engaged in creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company is focused on transforming the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. The Company's platform end-to-end solution comprised of the proteome analysis system, consumables, and software. The Company’s products include Proteome Analysis System, and Reagent Kits. Its proteome analysis system is a high-resolution optical imaging system coupled with integrated fluidics and liquid handling sub-systems. The Company’s Reagent Kits are comprised of four main components: sample preparation, flow cell(s), multi-affinity probe reagents, and instrument buffers used to perform multi-cycle analysis runs.

Contact Information

Headquarters

2701 Eastlake Ave EastSEATTLE, WA, United States 98102

Phone

206-333-2001

Fax

302-655-5049

Executives

Non-Executive Independent Chairman of the Board

Matthew Posard

President, Chief Executive Officer, Secretary, Director

Sujal Patel

Chief Financial Officer, Treasurer

Anna Mowry

Chief People Officer

Gwen Weld

Senior Vice President - Operations

Mary Godwin